Vildagliptin effective, well tolerated for type 2 diabetes

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2005

Schlagwörter:	Placebo Diabetes Mellitus Type Diabetes Mellitus Metformin Type Diabetes

Anmerkung:	© Adis International Ltd 2005

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1508(2005), 1 vom: Okt., Seite 6-6
Übergeordnetes Werk:	volume:1508 ; year:2005 ; number:1 ; month:10 ; pages:6-6

Links:	Volltext

DOI / URN:	10.2165/00128413-200515080-00015

Katalog-ID:	SPR035231467

Internformat


LEADER	01000caa a22002652 4500
001	SPR035231467
003	DE-627
005	20230520013111.0
007	cr uuu---uuuuu
008	201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200515080-00015 \|2 doi
035			\|a (DE-627)SPR035231467
035			\|a (SPR)00128413-200515080-00015-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Vildagliptin effective, well tolerated for type 2 diabetes
264		1	\|c 2005
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2005
650		4	\|a Placebo \|7 (dpeaa)DE-He213
650		4	\|a Diabetes Mellitus \|7 (dpeaa)DE-He213
650		4	\|a Type Diabetes Mellitus \|7 (dpeaa)DE-He213
650		4	\|a Metformin \|7 (dpeaa)DE-He213
650		4	\|a Type Diabetes \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1508(2005), 1 vom: Okt., Seite 6-6 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1508 \|g year:2005 \|g number:1 \|g month:10 \|g pages:6-6
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200515080-00015 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1508 \|j 2005 \|e 1 \|c 10 \|h 6-6

Indexfelder

matchkey_str	article:22306056:2005----::idgitnfetvwltlrtdo
hierarchy_sort_str	2005
publishDate	2005
allfields	10.2165/00128413-200515080-00015 doi (DE-627)SPR035231467 (SPR)00128413-200515080-00015-e DE-627 ger DE-627 rakwb eng Vildagliptin effective, well tolerated for type 2 diabetes 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Placebo (dpeaa)DE-He213 Diabetes Mellitus (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1508(2005), 1 vom: Okt., Seite 6-6 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1508 year:2005 number:1 month:10 pages:6-6 https://dx.doi.org/10.2165/00128413-200515080-00015 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1508 2005 1 10 6-6
spelling	10.2165/00128413-200515080-00015 doi (DE-627)SPR035231467 (SPR)00128413-200515080-00015-e DE-627 ger DE-627 rakwb eng Vildagliptin effective, well tolerated for type 2 diabetes 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Placebo (dpeaa)DE-He213 Diabetes Mellitus (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1508(2005), 1 vom: Okt., Seite 6-6 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1508 year:2005 number:1 month:10 pages:6-6 https://dx.doi.org/10.2165/00128413-200515080-00015 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1508 2005 1 10 6-6
allfields_unstemmed	10.2165/00128413-200515080-00015 doi (DE-627)SPR035231467 (SPR)00128413-200515080-00015-e DE-627 ger DE-627 rakwb eng Vildagliptin effective, well tolerated for type 2 diabetes 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Placebo (dpeaa)DE-He213 Diabetes Mellitus (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1508(2005), 1 vom: Okt., Seite 6-6 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1508 year:2005 number:1 month:10 pages:6-6 https://dx.doi.org/10.2165/00128413-200515080-00015 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1508 2005 1 10 6-6
allfieldsGer	10.2165/00128413-200515080-00015 doi (DE-627)SPR035231467 (SPR)00128413-200515080-00015-e DE-627 ger DE-627 rakwb eng Vildagliptin effective, well tolerated for type 2 diabetes 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Placebo (dpeaa)DE-He213 Diabetes Mellitus (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1508(2005), 1 vom: Okt., Seite 6-6 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1508 year:2005 number:1 month:10 pages:6-6 https://dx.doi.org/10.2165/00128413-200515080-00015 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1508 2005 1 10 6-6
allfieldsSound	10.2165/00128413-200515080-00015 doi (DE-627)SPR035231467 (SPR)00128413-200515080-00015-e DE-627 ger DE-627 rakwb eng Vildagliptin effective, well tolerated for type 2 diabetes 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Placebo (dpeaa)DE-He213 Diabetes Mellitus (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1508(2005), 1 vom: Okt., Seite 6-6 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1508 year:2005 number:1 month:10 pages:6-6 https://dx.doi.org/10.2165/00128413-200515080-00015 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1508 2005 1 10 6-6
language	English
source	Enthalten in Inpharma weekly 1508(2005), 1 vom: Okt., Seite 6-6 volume:1508 year:2005 number:1 month:10 pages:6-6
sourceStr	Enthalten in Inpharma weekly 1508(2005), 1 vom: Okt., Seite 6-6 volume:1508 year:2005 number:1 month:10 pages:6-6
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Placebo Diabetes Mellitus Type Diabetes Mellitus Metformin Type Diabetes
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2005-10-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035231467
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035231467</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520013111.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200515080-00015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035231467</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200515080-00015-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vildagliptin effective, well tolerated for type 2 diabetes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2005</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Placebo</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes Mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Type Diabetes Mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metformin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Type Diabetes</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1508(2005), 1 vom: Okt., Seite 6-6</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1508</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:6-6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200515080-00015</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1508</subfield><subfield code="j">2005</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">6-6</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Vildagliptin effective, well tolerated for type 2 diabetes Placebo (dpeaa)DE-He213 Diabetes Mellitus (dpeaa)DE-He213 Type Diabetes Mellitus (dpeaa)DE-He213 Metformin (dpeaa)DE-He213 Type Diabetes (dpeaa)DE-He213
topic	misc Placebo misc Diabetes Mellitus misc Type Diabetes Mellitus misc Metformin misc Type Diabetes
spellingShingle	misc Placebo misc Diabetes Mellitus misc Type Diabetes Mellitus misc Metformin misc Type Diabetes Vildagliptin effective, well tolerated for type 2 diabetes
topic_unstemmed	misc Placebo misc Diabetes Mellitus misc Type Diabetes Mellitus misc Metformin misc Type Diabetes
topic_browse	misc Placebo misc Diabetes Mellitus misc Type Diabetes Mellitus misc Metformin misc Type Diabetes
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Vildagliptin effective, well tolerated for type 2 diabetes
ctrlnum	(DE-627)SPR035231467 (SPR)00128413-200515080-00015-e
title_full	Vildagliptin effective, well tolerated for type 2 diabetes
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2005
contenttype_str_mv	txt
container_start_page	6
container_volume	1508
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200515080-00015
title_sort	vildagliptin effective, well tolerated for type 2 diabetes
title_auth	Vildagliptin effective, well tolerated for type 2 diabetes
abstract	© Adis International Ltd 2005
abstractGer	© Adis International Ltd 2005
abstract_unstemmed	© Adis International Ltd 2005
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Vildagliptin effective, well tolerated for type 2 diabetes
url	https://dx.doi.org/10.2165/00128413-200515080-00015
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200515080-00015
up_date	2024-07-03T13:55:56.719Z
_version_	1803566403259727872
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035231467</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520013111.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200515080-00015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035231467</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200515080-00015-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vildagliptin effective, well tolerated for type 2 diabetes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2005</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Placebo</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes Mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Type Diabetes Mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metformin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Type Diabetes</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1508(2005), 1 vom: Okt., Seite 6-6</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1508</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:6-6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200515080-00015</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1508</subfield><subfield code="j">2005</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">6-6</subfield></datafield></record></collection>
score	7.399893

Nicht das Richtige dabei?

Schreiben Sie uns!

Vildagliptin effective, well tolerated for type 2 diabetes

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?